- Karachaliou, Marianna
- Vidal, Marta
- Pembrey, Lucy
- Bustamante Pineda, Mariona
- Espinosa, Ana
- Mason, Dan
- Bañuls, Marc
- Casabonne, Delphine
- Roumeliotaki, Theano
- Bempi, Vicky
- Marin, Natalia
- Delgado-Saborit, Juana Maria
- Rodríguez Loreto, Santa Marina
- Ibarluzea, Jesús
- Vrijheid, Martine
- Aguilar, Ruth
- Dobaño, Carlota
- Kogevinas, Manolis
Objectives: To describe the epidemiology of common pathogens and risk factors among pregnant women and their children. Methods: In three European population-based birth cohorts, we examined 2213 mother-child pairs, contributing 5036 blood samples from pregnancy to 12 years of age. We measured serum immunoglobulin G levels against polyomaviruses (BKPyV, JCPyV, KIPyV, WUPyV, MCPyV), herpesviruses (Epstein-Barr virus [EBV], cytomegalovirus [CMV], varicella-zoster virus), adenovirus 36, Helicobacter pylori, and Toxoplasma gondii with multiplex serology. Results: Among pregnant women, seroprevalence ranged from 18.7% (H. pylori) to 95.7% (EBV); among 4-6-year-old children, seroprevalence ranged from 3.6% (H. pylori) to 88.4% (BKPyV). Although most primary infections occurred in the first 4 years of life, some children had primary infections at later ages. Seropositive mothers were more likely to have seropositive children, but an intergenerational decrease in seroprevalence was evident for herpesviruses and H. pylori. There were sizeable differences between countries for H. pylori and T. gondii. Non-western ethnicity mothers and their children were more likely to be infected. Female sex (WUPyV, MCPyV, CMV), breastfeeding (CMV), early daycare attendance (CMV, H. pylori), and obesity (JCPyV, EBV, Adv-36) were associated with child's seroprevalence. Conclusions: European children acquire common pathogens but often experience first exposure beyond early childhood. Differences are expected between and within countries and across generations., La Marato de TV3 2017, Project number 201819, Reg. 78 / 437, Title “Infection acquisition in early life and health outcomes in childhood.” INMA Sabadell: This study was funded by grants from Instituto de Salud Carlos III (Red INMA G03/176; CB06/02/0041; PI041436; PI081151 incl. FEDER funds). CIBERESP, Generalitat de Catalunya-CIRIT 1999SGR 00241, Generalitat de Catalunya-AGAUR 2009. SGR 501, Fundació La marató de TV3 (090430). EU Commission (261357). We acknowledge support from the grant CEX2023-0001290-S funded by MCIN/AEI/10.13039/501100011033 and support from the Generalitat de Catalunya through the CERCA Program. INMA Valencia: This study was funded by Grants from UE (FP7-ENV-2011 cod 282957, HEALTH.2010.2.4.5-1, cod 874583, and cod 101136566), Spain: ISCIII (G03/176; FIS-FEDER: PI03/1615, PI04/1509, PI06/1213, PI11/01007, PI11/02591, PI11/02038, PI12/00610, PI13/1944, PI13/2032, PI14/00891, PI14/01687, PI16/1288, PI17/00663, PI19/1338; P 23/1578). Miguel Servet-FEDER CP11/00178, CP15/00025, MSII16/00051, MS20/0006, CP15. Spanish Ministry of Universities (Margarita Salas Grant MS21-133. grant CAS21/00008), Generalitat Valenciana (CIAICO/2021/132, BEST/2020/059, AICO 2020/285, AICO/2021/182, and CIDEGENT/2019/064), Consejo General de Enfermería (PNI22_CGE45), FISABIO (UGP 15-230, UGP-15-244, UGP-15-249), and Alicia Koplowitz Foundation 2017. INMA Gipuzcoa: This study was funded by grants from Instituto de Salud Carlos III (FIS-PI06/0867, FIS-PI09/00090, FIS-PI13/02187, FIS-PI18/01142 include FEDER funds and FIS-PI18/01237 include FEDER funds), CIBERESP, Department of Health of the Basque Government (2005111093, 2009111069, 2013111089, 2015111065, and 2018111086), and the Provincial Government of Gipuzkoa (DFG06/002, DFG08/001 and DFG15/221, and DFG 89/17) and annual agreements with the municipalities of the study area (Zumarraga, Urretxu, Legazpi, Azkoitia y Azpeitia y Beasain). Born in Bradford is supported by a Wellcome programme grant [223601; Born in Bradford: Age of Wonder] and the National Institute for Health Research under its Applied Research Collaboration Yorkshire and Humber, Grant number: NIHR200166. The "Rhea" project was financially supported by European projects (EU FP6-2003-Food-3-NewGeneris, EU FP6. STREP Hiwate, EU FP7 NV.2007.1.2.2.2. Project No 211250 Escape, EU FP7-2008-ENV-1.2.1.4 Envirogenomarkers, EU FP7-HEALTH-2009-single stage CHICOS, EU FP7 ENV.2008.1.2.1.6. Proposal No 226285 ENRIECO, EU- FP7- HEALTH-2012 Proposal No 308333 HELIX, EU FP7-no. 264357 EU H2020 No. 733206, LIFE-CYCLE) and the Greek Ministry of Health (Program of Prevention of Obesity and Neurodevelopmental Disorders in Preschool Children, in Heraklion district, Crete, Greece: 2011-2014; “Rhea Plus”: Primary Prevention Program of Environmental Risk Factors for Reproductive Health, and Child Health: 2012-15). Marianna Karachaliou has received funding from the European Union’s Horizon Europe research and innovation program under the Marie Skłodowska-Curie Actions (MSCA) Postdoctoral Fellowships (grant no. 101152509). DC was partially supported by Instituto de Salud Carlos III (ISCIII, Spanish Government) co-funded by FEDER funds/European Regional Development Fund (ERDF), a way to build Europe (CIBERESP CB06/02/0073, PI20/00288), also with the support of the Secretariat for Universities and Research of the Ministry of Business and Knowledge of the Government of Catalonia (2021SGR01354). The funders had no role in the study design, data collection and analysis, interpretation of data, preparation of the manuscript, and decision to publish.